A two-locus genetic interaction between LPHN3 and 11q predicts ADHD severity and long-term outcome

Translational Psychiatry

Volumn 1, Issue , 2011, Pages

  Acosta, M T ^a   Velez J I ^a   Bustamante, M L ^a,b,c   Balog, J Z ^a   Arcos Burgos, M ^a   Muenke, M ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CHILE   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

ADHD; DRD2; Epistasis; LPHN3; NCAM1; Severity of symptoms

Indexed keywords

DOPAMINE 2 RECEPTOR; G PROTEIN COUPLED RECEPTOR; LPHN3 PROTEIN, HUMAN; RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CHROMOSOME 11; FEMALE; GENE LOCUS; GENETIC EPISTASIS; GENETICS; GENOTYPE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX; TIME;

ADOLESCENT; ADULT; AGED; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 11; EPISTASIS, GENETIC; FEMALE; GENETIC LOCI; GENOTYPE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, DOPAMINE D2; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; YOUNG ADULT;

EID: 79960354245     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2011.14     Document Type: Article

References (36)

1. Visser S, Bitsko R, Danielson M, Perou R. Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children - United States, 2003 and 2007. Mortal Morb Wkly Rep 2010;59:1439-1443.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edn, text revision ed. American psychiatric Association: Washington, DC, 2000.
3. Danckaerts M, Sonuga-Barke EJ, Banaschewski T, Buitelaar J, Dopfner M, Hollis C et al. The quality of life of children with attention deficit/hyperactivity disorder: a systematic review. Eur Child Adolesc Psychiatry 2010;19:83-105.
4. Barry T, Lyman R, Klinger L. Academic underachievement and attention-deficit/hyperactivity disorder: the negative impact of symptom severity on school performance. J Sch Psychol 2002;40:259-283.
5. Riley AW, Spiel G, Coghill D, Dopfner M, Falissard B, Lorenzo MJ et al. Factors related to health-related quality of life (HRQoL) among children with ADHD in Europe at entry into treatment. Eur Child Adolesc Psychiatry 2006;15(Suppl 1):I38-I45.
6. Upadhyaya HP, Carpenter MJ. Is attention deficit hyperactivity disorder (ADHD) symptom severity associated with tobacco use? Am J Addict 2008;17:195-198. (Pubitemid 351883178)
7. Norvilitis JM, Sun L, Zhang J. ADHD symptomatology and adjustment to college in China and the United States. J Learn Disabil 2010;43:86-94.
8. Acosta MT, Castellanos FX, Bolton KL, Balog JZ, Eagen P, Nee L et al. Latent class subtyping of attention-deficit/hyperactivity disorder and comorbid conditions. J Am Acad Child Adolesc Psychiatry 2008;47:797-807.
9. Todd RD, Sitdhiraksa N, Reich W, Ji TH, Joyner CA, Heath AC et al. Discrimination of DSM-IV and latent class attention-deficit/hyperactivity disorder subtypes by educational and cognitive performance in a population-based sample of child and adolescent twins. J Am Acad Child Adolesc Psychiatry 2002;41:820-828. (Pubitemid 38338098)
10. Volk HE, Henderson C, Neuman RJ, Todd RD. Validation of population-based ADHD subtypes and identification of three clinically impaired subtypes. Am J Med Genet B Neuropsychiatr Genet 2006;141B:312-318.
11. Acosta MT, Arcos-Burgos M, Muenke M. Attention deficit/hyperactivity disorder (ADHD): complex phenotype, simple genotype? Genet Med 2004;6:1-15. (Pubitemid 38175972)
12. Arcos-Burgos M, Jain M, Acosta MT, Shively S, Stanescu H, Wallis D et al. A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol Psychiatry 2010;15:1053-1066.
13. Ribases M, Ramos-Quiroga JA, Sanchez-Mora C, Bosch R, Richarte V, Palomar G et al. Contribution of LPHN3 to the genetic susceptibility to ADHD in adulthood: a replication study. Genes Brain Behav 2010;10:149-157.
14. Jain M, Vélez J, Acosta M, Balog J, Roessler E, Palacio L et al. A cooperative interaction between LPHN3 and 11q doubles the risk for ADHD. Mol Psychiatry 2011 May 24 (e-pub ahead of print).
15. Xiao MF, Xu JC, Tereshchenko Y, Novak D, Schachner M, Kleene R. Neural cell adhesion molecule modulates dopaminergic signaling and behavior by regulating dopamine D2 receptor internalization. J Neurosci 2009;29:14752-14763.
16. Lucht M, Samochowiec A, Samochowiec J, Jasiewicz A, Grabe HJ, Geissler I et al. Influence of DRD2 and ANKK1 genotypes on apomorphine-induced growth hormone (GH) response in alcohol-dependent patients. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:45-49.
17. Schiff M, Weinhold B, Grothe C, Hildebrandt H. NCAM and polysialyltransferase profiles match dopaminergic marker gene expression but polysialic acid is dispensable for development of the midbrain dopamine system. J Neurochem 2009;110:1661-1673.
18. Bisaz R, Schachner M, Sandi C. Causal evidence for the involvement of the neural cell adhesion molecule, NCAM, in chronic stress-induced cognitive impairments. Hippocampus 2011;21:56-71.
19. Cox ET, Brennaman LH, Gable KL, Hamer RM, Glantz LA, Lamantia AS et al. Developmental regulation of neural cell adhesion molecule in human prefrontal cortex. Neuroscience 2009;162:96-105.
20. Kollins SH, Anastopoulos AD, Lachiewicz AM, FitzGerald D, Morrissey-Kane E, Garrett ME et al. SNPs in dopamine D2 receptor gene (DRD2) and norepinephrine transporter gene (NET) are associated with continuous performance task (CPT) phenotypes in ADHD children and their families. Am J Med Genet B Neuropsychiatr Genet 2008;147B:1580-1588.
21. Conners C, Erhardt D, Sparrow E. The Conners Adult ADHD Rating Scale (CAARS). Multi-Health Systems Inc.: Toronto, 1998.
22. Wolraich ML, Lambert W, Doffing MA, Bickman L, Simmons T, Worley K. Psychometric properties of the Vanderbilt ADHD diagnostic parent rating scale in a referred population. J Pediatr Psychol 2003;28:559-567. (Pubitemid 37449138)
23. Lindgren S, Koeppl G. Assessing child behavior problems in a medical setting: development of the Pediatric Behavior Scale. In: Prinz R, (ed). Advances in Behavioral Assessment of Children and Families. JAI Press: Greenwich, CT, 1987, pp. 57-90.
24. Vermunt J, Magidson J. Latent class cluster analysis. In: Haagenars J, AL M, (eds). Applied Latent Class Analysis. Cambridge University Press: Cambridge, UK, 2002.
25. Arcos-Burgos M, Castellanos FX, Pineda D, Lopera F, Palacio JD, Palacio LG et al. Attention-deficit/hyperactivity disorder in a population isolate: linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11. Am J Hum Genet 2004;75:998-1014. (Pubitemid 39532070)
26. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, 2010.
27. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B (Methodological) 1995;57:289-300.
28. Hudziak JJ, Heath AC, Madden PF, Reich W, Bucholz KK, Slutske W et al. Latent class and factor analysis of DSM-IV ADHD: a twin study of female adolescents. J Am Acad Child Adolesc Psychiatry 1998;37:848-857. (Pubitemid 28354819)
29. Rohde LA, Barbosa G, Polanczyk G, Eizirik M, Rasmussen ER, Neuman RJ et al. Factor and latent class analysis of DSM-IVADHD symptoms in a school sample of Brazilian adolescents. J Am Acad Child Adolesc Psychiatry 2001;40:711-718. (Pubitemid 32473386)
30. Jain M, Palacio LG, Castellanos FX, Palacio JD, Pineda D, Restrepo MI et al. Attentiondeficit/hyperactivity disorder and comorbid disruptive behavior disorders: evidence of pleiotropy and new susceptibility loci. Biol Psychiatry 2007;61:1329-1339. (Pubitemid 46855764)
31. Elia J, Arcos-Burgos M, Bolton KL, Ambrosini PJ, Berrettini W, Muenke M. ADHD latent class clusters: DSM-IV subtypes and comorbidity. Psychiatry Res 2009;170:192-198.
32. Esposito-Smythers C, Spirito A, Rizzo C, McGeary JE, Knopik VS. Associations of the DRD2 TaqIA polymorphism with impulsivity and substance use: preliminary results from a clinical sample of adolescents. Pharmacol Biochem Behav 2009;93:306-312.
33. Forbes EE, Brown SM, Kimak M, Ferrell RE, Manuck SB, Hariri AR. Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. Mol Psychiatry 2009;14:60-70.
34. Kochlamazashvili G, Senkov O, Grebenyuk S, Robinson C, Xiao MF, Stummeyer K et al. Neural cell adhesion molecule-associated polysialic acid regulates synaptic plasticity and learning by restraining the signaling through GluN2B-containing NMDA receptors. J Neurosci 2010;30:4171-4183.
35. Maness PF, Schachner M. Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration. Nat Neurosci 2007;10:19-26. (Pubitemid 46026522)
36. Palacio JD, Castellanos FX, Pineda DA, Lopera F, Arcos-Burgos M, Quiroz YT et al. Attention-deficit/hyperactivity disorder and comorbidities in 18 Paisa Colombian multigenerational families. J Am Acad Child Adolesc Psychiatry 2004;43:1506-1515. (Pubitemid 40468625)